Actigraphy Sensors & PSG Devices Market Set to Deliver Major Revenue Shares duri

Posted by Arslan on January 30th, 2019

 Fitbit, Inc., a U.S.-based player in the actigraphy sensor and PSG devices market, announced the launch of a new enterprise – Fitbit Care™. With the launch of Fitbit Care, the company has introduced a new platform for enhancing wellness, prevention, and disease management regimes.

The Fitbit Care platform features a wide range of devices including wearables and self-tracking devices that continuously track sleep-related activities and other personalized digital interventions for specific disease management.

Aetna Inc., an American healthcare company, was recently acquired by CVS Health Corporation, which is also an American retail pharmacy and health care company, for approximately US$ 78 billion. The combined company aims to offer powerful health resources and advanced connected medical devices to gain momentum in the health care industry.

The US$ 1.78 billion actigraphy sensor and PSG devices market on course to grow at 4.3% in 2019, according to Fact.MR’s latest analysis. According to the study, actigraphy sensor and PSG devices market remains a highly consolidated landscape, with Tier I companies maintaining their hegemony despite the foray of new entrants.

According to the study, as a result of the convergence of healthcare and technology, new medical technology (MedTech) products are gaining ground. Growing consumer awareness about—and inclination towards—technologically advanced actigraphy sensor and PSG devices has attracted both, tech industry leaders and startups, to enter the healthcare industry with more innovative actigraphy sensor and PSG devices.

Growing Prevalence of Sleep Disorders Triggering Demand

The modern lifestyle has altered sleeping patterns, leading to an increase in the prevalence of various sleep disorders. Right from minor sleep disturbances to major problems, such as insomnia, chronic sleep disorders have adverse impacts on consumers’ quality of life. As actigraphy sensor and PSG devices make it simpler for users to monitor their sleep duration with more convenience and accuracy, it helps in diagnosing sleep diseases reliably and makes treatments more effective.

Thereby, consumers are seeking diagnostic services for the accurate treatments of sleep disorders, which is creating a high demand for actigraphy sensor and PSG devices in the healthcare sector. Furthermore, ongoing research in the field of sleep disorder management to discover more efficient medicine and treatments for life-threatening sleep disorders is providing a boost to the applications of actigraphy sensor and PSG devices.


Browse Full Report with TOC-

Ever-expanding End-user Base of Health-conscious Consumers is Creating Lucrative Sales Opportunities

With the incidences of severe sleep disorders reaching its peak, health-conscious consumers are willing to opt for effective treatments in order to improve the quality of life. The quest for adopting a healthier lifestyle is predominantly boosting sales of actigraphy sensor and PSG devices among health-conscious consumers.

Furthermore, a substantial rise in the geriatric population has a hand in the rapidly expanding base of target consumers for manufacturers in the actigraphy sensor and PSG devices market. Thereby, with the growing popularity of health and wellness trends, the sales of actigraphy sensor and PSG devices are likely to multiply at a rapid rate in the upcoming years.

Like it? Share it!


About the Author

Joined: December 18th, 2017
Articles Posted: 13,297

More by this author